Mayne Pharma (MYX:ASX)

Last update - 15 May 2025 By Shannon Rivkin

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.

We are glad you are enjoying our content and we’d like to help you achieving your financial goals.

This content is only for Rivkin Report Members.

Start a free 14-day trial to access this article and:

  • 6 Model Portfolios for Income and Growth

  • In-Depth Stock Analysis: identify potential investment opportunities

  • Q&A sessions with our CIO, Shannon Rivkin

Be the first to know. Get the Morning Market Wrap each morning.